• Product NameImiquimod
• Brief DescriptionInhibitors
• Purification99.50%
• Biological ActivityImiquimod is an immune response modifier that acts as a toll-like receptor 7 agonist. Imiquimod is commonly used topically to treat warts on the skin of the genital and anal areas. Imiquimod does not cure warts, and new warts may appear during treatment. Imiquimod does not fight the viruses that cause warts directly, however, it does help to relieve and control wart production. Miquimod is also used to treat a skin condition of the face and scalp called actinic keratoses and certain types of skin Y called superficial basal cell carcinoma.
• Target NameTLR agonist
• CAS No. 99011-02-6
• Calculated MW 240.31
• Formulation C14H16N4
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:CC(C)CN1C=NC2=C1C1=CC=CC=C1N=C2N
  Pathways:Immunology/Inflammation
  Receptor:TLR7; TLR8
  Boling pt:456.7C
  Melting pt:292-294C
  Solubility:DMSO: 0.01 mg/mL (0.04 mM)
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Gibson SJ, et al. Cell Immunol. 2002 Jul-Aug;218(1-2):74-86.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting